Company: PTHS
Filing Date: 2025-09-16
Form Type: 8-K/A
Source: 0001753926-25-001500
Chunk: 96

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-09-16
Form: 8-K/A
Chunk 96
---
 our Chief Commercial Officer.

Summary Compensation Table

The following table provides information regarding the compensation of our named executive officers during the years ended December 31, 2024 and 2023.

| Name and Principal Position                                                                 |     | Year |     | Salary |         |    |     | Bonus |        |     | Option 
 Awards |         |     | Non-Equity     
 Incentive Plan 
 Compensation   |   |     | All Other    
 Compensation |   |     | Total |         |
|:--------------------------------------------------------------------------------------------|:----|-----:|:----|:-------|--------:|---:|:----|:------|-------:|:----|:-------|--------:|:----|:---------------|:--|:----|:-------------|:--|:----|:------|--------:|
| Scott Plesha(1)                                                                             |     | 2024 |     | $      |       — |    |     | $     |      — |     | $      |       — |     | $              | — |     | $            | — |     | $     |       — |
| Chief Executive Officer                                                                     |     | 2023 |     | $      |       — |    |     | $     |      — |     | $      |       — |     | $              | — |     | $            | — |     | $     |       — |
| Francis Knuettel II                                                                         |     | 2024 |     | $      | 424,923 |    |     | $     | 56,666 |     | $      | 361,833 |     | $              | — |     | $            | — |     | $     | 843,422 |
| Chief Financial Officer (2)                                                                 |     | 2023 |     | $      | 107,500 |    |     | $     |      — |     | $      | 199,510 |     | $              | — |     | $            | — |     | $     | 307,010 |
| Sai Rangarao (3)                                                                            |     | 2024 |     | $      |       — |    |     | $     |      — |     | $      |       — |     | $              | — |     | $            | — |     | $     |         |
| Chief Commercial Officer                                                                    |     | 2023 |     |